ENGROSSEDAn Act ENROLLED HOUSE BILL NO.
Stinson, ArcherArcher, Roe, and RoeMiller of the House and Hines of the Senate 6 An Act relating to schools;
BESUBJECT: IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
Schools BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
Notwithstanding the provisions of Section 1-116.2 of this title, the board of education of each school ENGR.district shall adopt a policy on or before September 1, 2008, that permits the self-administration of inhaled asthma medication by a student for treatment of asthma, the self-administration of anaphylaxis medication by a student for treatment of anaphylaxis and the self-administration of replacement pancreatic enzymes by a student for treatment of cystic fibrosis.
H.
B.
NO.
2047 Page 1 district shall adopt a policy on or before September 1, 2008, that permits the self-administration of inhaled asthma medication by a student for treatment of asthma, the self-administration of anaphylaxis medication by a student for treatment of anaphylaxis and the self-administration of replacement pancreatic enzymes by a student for treatment of cystic fibrosis.
The parent or guardian of the student to sign a statement acknowledging that the school district shall incur no liability as a ENGR.result of any injury arising from the self-administration of medication by the student.
H.
NO.
2047 Page 2 result of any injury arising from the self-administration of medication by the student.
B.
the school district to inform the parent or guardian of each student, in writing, that a school nurse or school employee trained by a health care professional or trained in correlation with the State Department of Health's Diabetes Management Annual School Training Program pursuant to subsection G of this section may administer, with parent or guardian permission but without a health care provider order, an Epinephrine injection to a student whom the school nurse or trainedENR. school employee in good faith believes is having an anaphylactic reaction, b.
a waiver of liability executed by a parent or guardian be on file with the school district prior to the administration of an Epinephrine injection pursuant to paragraph 1 of this subsection, and c.
the school district to designate the employee responsible for obtaining the Epinephrine injectors at each school site.
ENGR.
2047 Page 32 2.trained school employee in good faith believes is having an anaphylactic reaction, b.
a waiver of liability executed by a parent or guardian be on file with the school district prior to the administration of an Epinephrine injection pursuant to paragraph 1 of this subsection, and c.
the school district to designate the employee responsible for obtaining the Epinephrine injectors at each school site.
2.
Such physician shall incur no liability as a result of any injury arising from the ENGR.use of the Epinephrine injectors or the inhalers and spacers or holding chambers.
E.
The school district may maintain at each school a minimum of two Epinephrine injectors devices and two inhalers with spacers or ENR.
2047 Page 43 useholding ofchambers thein Epinephrinea injectorssecure orlocation. the inhalers and spacers or holding chambers.
E.
The school district may maintain at each school a minimum of two Epinephrine injectors devices and two inhalers with spacers or holding chambers in a secure location.
Documentation certifying completion of the ENGR.required training shall be retained in the personnel file of the teacher or school employee.
H.
B.
NO.
2047 Page 5 required training shall be retained in the personnel file of the teacher or school employee.
and 4.ENR.
"Inhaler" means a device that delivers a bronchodilator to alleviate symptoms of respiratory distress that is manufactured in the form of a metered-dose inhaler or dry-powder inhaler and that may include a spacer or holding chamber that attaches to the inhaler to improve the delivery of the bronchodilator.
ENGR.
2047 Page 64 J.4.
"Inhaler" means a device that delivers a bronchodilator to alleviate symptoms of respiratory distress that is manufactured in the form of a metered-dose inhaler or dry-powder inhaler and that may include a spacer or holding chamber that attaches to the inhaler to improve the delivery of the bronchodilator.
J.
PassedENR. the House of Representatives the 26th day of March, 2025.
Presiding Officer of the House of Representatives Passed the Senate the _____ day of __________, 2025.
Presiding Officer of the Senate ENGR.
2047 Page 75 Passed the House of Representatives the 26th day of March, 2025.
Presiding Officer of the House of Representatives Passed the Senate the 6th day of May, 2025.
Presiding Officer of the Senate OFFICE OF THE GOVERNOR Received by the Office of the Governor this ____________________ day of ___________________, 20_______, at _______ o'clock _______ M.
By:
_________________________________ Approved by the Governor of the State of Oklahoma this _________ day of ___________________, 20_______, at _______ o'clock _______ M.
_________________________________ Governor of the State of Oklahoma OFFICE OF THE SECRETARY OF STATE Received by the Office of the Secretary of State this __________ day of ___________________, 20_______, at _______ o'clock _______ M.
By:
_________________________________ ENR.
H.
B.
NO.
2047 Page 6